GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
